Troy E Messick

5PUBLICATIONS
26CO-AUTHORS
Molecular targetsNeural engineeringEconometric and statistical methodsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 20, 2025
First-in-Human Clinical Trial of a Small-Molecule EBNA1 Inhibitor, VK-2019, in Patients with Epstein-Barr-Positive Nasopharyngeal Cancer, with Pharmacokinetic and Pharmacodynamic Studies.

A Dimitrios Colevas, Zahra Talebi, Elizabeth Winters

|Nov 09, 2023
Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of VK-2019, a selective EBNA1 inhibitor.

Michael T Davis, Nicole M Anders, A Dimitrios Colevas

|Jun 09, 2021
Epigenetic Plasticity Enables CNS-Trafficking of EBV-infected B Lymphocytes.

Samantha S Soldan, Chenhe Su, R Jason Lamontagne

|Apr 30, 2021
EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein-Barr virus-associated gastric cancer.

Samantha S Soldan, Emma M Anderson, Drew M Frase

|Mar 08, 2019
Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth.

Troy E Messick, Garry R Smith, Samantha S Soldan

Pageof 1

Frequent Collaborators

2 joint publications

Samantha S Soldan

2 joint publications

Paul M Lieberman

1 joint publications

Garry R Smith

1 joint publications

Mark E McDonnell